857230P

C18:1 LPA

1-(9Z-octadecenyl)-2-hydroxy-sn-glycero-3-phosphate (ammonium salt), powder

• Sinónimos: 1-O-9-(Z)-octadecenyl-sn-glycero-3-phosphate (ammonium salt); PA(18:1(9Z)e/0:0)
• Fórmula empírica (notación de Hill): C₂₁H₄₆NO₆P
• Número de CAS: 799279-68-8
• Peso molecular: 439.57
• Código UNSPSC: 51191904
• NACRES: NA.25

Propiedades

• Ensayo: >99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
• Formulario: powder
• envase: pkg of 1 × 1 mg (857230P-1mg)
• fabricante / nombre comercial: Avanti Research^™ - A Croda Brand 857230P
• tipo de lípido: cardiolipins; phospholipids
• Condiciones de envío: dry ice
• temp. de almacenamiento: −20°C
• cadena SMILES: O[C@](COP([O-])(O)=O)([H])COCCCCCCCC/C=C\CCCCCCCC.[NH4+]
• Clave InChI: WEOSAIXAEGBVPQ-WBIWQBECSA-N

Descripción

Descripción general

C18:1 LPA is a bioactive lipid. This lysophosphatidic acid (LPA), soluble lipid is obtained from membrane phospholipid. It is present in blood plasma.

Aplicación

C18:1 LPA is suitable to stimulate human embryonic kidney 293 cells (HEK 293) cells in luciferase assay. It is also suitable to use as an additive in Dulbecco′s modified eagle medium (DMEM) for transwell migration assay, wound‐healing assay and cell proliferation assay.

Acciones bioquímicas o fisiológicas

Lysophosphatidic acid (LPA) signaling participates in various cellular processes. It is also associated with neurological disorders, inflammation and cancer.

Envase

5 mL Clear Glass Sealed Ampule (857230P-1mg)

Información legal

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Información de seguridad

• Código de clase de almacenamiento: 11 - Combustible Solids
• Clase de riesgo para el agua (WGK): WGK 3
• Punto de inflamabilidad (°F): No data available
• Punto de inflamabilidad (°C): No data available